Patent · US Active

Biological indicator

US9102976B2 · kind B2 · utility

4Cited by
5References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 2013
Grant dateAug 11, 2015
Priority date
Expiry dateFeb 25, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/22
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A kinase is used in a biological indicator for validation of treatment processes designed to reduce the amount or activity of a biological agent in a sample. The indication can be used for validation of sterilization treatment. The formation of ATP from a substrate comprising ADP is measured via the liciferin/luciferate system in a luminameter. Thermostable adenylate kinase from sulfolobus acidocaldarius is especially suitable for the validation of procedures to inactivate transmissable spongiform encephalopathy agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.